Previous Close | 22.20 |
Open | 22.20 |
Bid | 22.00 x N/A |
Ask | 22.20 x N/A |
Day's Range | 22.20 - 22.20 |
52 Week Range | 12.60 - 25.60 |
Volume | |
Avg. Volume | 3 |
Market Cap | N/A |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
The average of price targets set by Wall Street analysts indicates a potential upside of 77.2% in Bicycle Therapeutics (BCYC). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Bicycle Therapeutics ( NASDAQ:BCYC ) First Quarter 2024 Results Key Financial Results Revenue: US$19.5m (up 299% from...
Comparison with Analyst Estimates and Strategic Developments